Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: Biopharma tackles legislative, regulatory, market hurdles at BIO 2012

This article was originally published in Scrip

Executive Summary

While Washington was immersed in predicting the US Supreme Court's verdict on health care reform – with some soothsayers inevitably off beam – biopharmaceutical leaders from 65 countries last week were engaged 450 miles (724.2 kilometers) to the north in Boston in the largest networking discussion aimed at finding legislative, regulatory, scientific and market solutions for ensuring the viability of their companies and the industry at large.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC017843

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel